Bloomberg Advantage- Pfizer, Allergan $160 Billion Deal Killled
[]
http://www.bloomberg.com/news/audio/2016-04-06/bloomberg-advantage-pfizer-allergan-160-billion-deal-killled
(Bloomberg) -- The Bloomberg Advantage with Carol Massar and Cory Johnson. GUEST: Cynthia Koons Health Care Reporter Bloomberg News Discussing Pfizer Inc. and Allergan Plc have terminating their $160 billion merger in an abrupt end to the largest-ever health-care deal after the U.S. government cracked down on corporate tax inversions.

Running time 08:00

Download: Bloomberg Advantage: Pfizer, Allergan $160 Billion Deal Killled
